NCT03639285Recruiting

Natural History, Diagnosis, and Outcomes for Leukodystrophies

University of Utah

Start Date

1/19/2007

Completion Date

12/31/2050

Summary

The goals of this protocol is to diagnose, care for, and understand the clinical histories and outcomes of people with leukodystrophies.

Detailed Description

Inherited leukodystrophies affect close to 1 in 7500 children with mortality greater than 30%. Affected patients face additional serious medical complications including epilepsy, developmental regression, and intellectual disabilities. Diagnosis is difficult and requires the assistance of a specialist. Finally, identifying treatments and improving outcomes is complex. The Western Leukodystrophy Project, which is part of the University of Utah and of Primary Children's Hospital, and which is a certified Leukodystrophy Care Network Center, provides a specialized resource for patients with leukodystrophies. This clinical study assists with diagnosis of leukodystrophies; suggesting treatment options and implementing care guidelines, and improving outcomes for all patients by understanding the clinical histories and outcomes of affected patients..

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * evidence by clinical exam, radiological findings, and/or testing, of an inherited leukodystrophy. * be able to travel to the leukodystrophy clinic (at Primary Children's Hospital, Salt Lake City, Utah); * be able to tolerate a general physical exam, and a neurological exam. Exclusion Criteria: * unable to be evaluated at the University of Utah Hospital or Primary Children's Hospital; * refusal to sign study consent form; * evidence or finding of another non-genetic cause of their condition; * Persons with known white matter disease or lesions related to: birth injury or prenatal injury, multiple sclerosis, trauma, infection, immunization, or post-infectious effects (e.g. ADEM- acute disseminated encephalomyelitis), metabolic disturbance (e.g. Central pontine myelinolysis), neoplasms, primary rheumatologic diseases (e.g. Systemic lupus erythematosis), stroke, hypoxic-ischemic injury, drug or toxin effect, seizures, or endocrine disturbance.

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Leukodystrophy

Locations

Primary Children's Hospital

Salt Lake City, Utah 84113

United States